(Q40914172)

24 September 2017

1 reference

title

Biopharmaceutical aspects of lipid formulations of amphotericin B. (English)

1 reference

24 September 2017

Storm G

1

1 reference

PubMed ID

9063676

24 September 2017

van Etten E

series ordinal

2

1 reference

24 September 2017

1 January 1997

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

24 September 2017

1 reference

24 September 2017

16

1 reference

24 September 2017

1

1 reference

24 September 2017

64-73

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01575123

24 September 2017

0 references

cites work

Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomes

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01575123

Effect of attachment of anticandidal antibody to the surfaces of liposomes encapsulating amphotericin B in the treatment of murine candidiasis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01575123

Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01575123

Amphotericin B in liposomes: a novel therapy for histoplasmosis

21 January 2018

1 reference

12 December 2020

Liposomes: preparation, characterization, and preservation

1 reference

12 December 2020

Evaluation of antibody-bearing liposomal amphotericin B in the treatment of systemic candidiasis in a neutropenic murine model

1 reference

12 December 2020

Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors

1 reference

12 December 2020

Modification of amphotericin B's therapeutic index by increasing its association with serum high-density lipoproteins

1 reference

12 December 2020

Clinical use of liposomal and lipid-complexed amphotericin B.

1 reference

12 December 2020

Technetium-labelled liposome imaging for deep-seated infection

1 reference

12 December 2020

Vascular and interstitial barriers to delivery of therapeutic agents in tumors

1 reference

12 December 2020

Treatment of systemic candidiasis in a neutropenic murine model using immunoglobulin G bearing liposomal amphotericin B

1 reference

12 December 2020

Sterically stabilized liposomes

1 reference

12 December 2020

Fate and behavior of liposomes in vivo: a review of controlling factors

1 reference

12 December 2020

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

12 December 2020

Treatment of systemic fungal infections with liposomal amphotericin B.

1 reference

12 December 2020

Synovial accumulation of technetium labelled liposomes in rheumatoid arthritis

1 reference

12 December 2020

Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma

1 reference

12 December 2020

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

1 reference

12 December 2020

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies

1 reference

12 December 2020

Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity

1 reference

12 December 2020

Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue

1 reference

12 December 2020

Epidemiology and control of fungal infections.

1 reference

12 December 2020

Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics

1 reference

12 December 2020

Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B

1 reference

12 December 2020

Sterically stabilized liposomes labeled with indium-111 to image focal infection

1 reference

12 December 2020

Treatment of a murine model of systemic candidiasis with liposomal amphotericin B bearing antibody to Candida albicans

1 reference

12 December 2020

Treatment of murine cryptococcosis with liposome-associated amphotericin B

1 reference

12 December 2020

Amphotericin B: 30 years of clinical experience

1 reference

12 December 2020

Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.

1 reference

12 December 2020

Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes

1 reference

12 December 2020

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.

1 reference

12 December 2020

Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal amphotericin B

1 reference

12 December 2020

Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue

1 reference

12 December 2020

Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes

1 reference

12 December 2020

Biological approaches to the controlled delivery of drugs: a critical review.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01575123

1 reference

PubMed ID

9063676

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

9063676